Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Dávalos Salas, Mercedes ^a   Furlan Magaril, Mayra ^a   González Buendía, Edgar ^a   Valdes Quezada, Christian ^a   Ayala Ortega, Erandi ^a   Recillas Targa, Félix ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; DNA; GENOMIC DNA; GREEN FLUORESCENT PROTEIN; METHYL CPG BINDING PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR CTCF; TRICHOSTATIN A; AZACITIDINE; CCCTC-BINDING FACTOR; DRUG DERIVATIVE; HYDROXAMIC ACID; REPRESSOR PROTEIN;

ARTICLE; BINDING SITE; CANCER CELL CULTURE; CELL STRAIN K 562; CELL STRAIN SHSY 5Y; CELL STRAIN T98G; CELL STRAIN U73MG; CELL STRAIN U87MG; CELL TRANSFORMATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOMETRY; DNA METHYLATION; EPIGENETICS; FLUORESCENT CYTOMETRY; GENE ACTIVATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE ISOLATION; GENE MUTATION; GENE SILENCING; GLIOMA CELL; HELA CELL; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; STABLE TRANSFECTION; TRANSGENE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; CHEMISTRY; CONFORMATION; DNA SEQUENCE; DOWN REGULATION; GENETICS; GLIOMA; MUTATION; PATHOLOGY; PHYSIOLOGY; REPORTER GENE; TUMOR CELL LINE;

AZACITIDINE; BINDING SITES; CELL LINE, TUMOR; DNA METHYLATION; DNA, NEOPLASM; DOWN-REGULATION; GENES, REPORTER; GENES, RETINOBLASTOMA; GLIOMA; HELA CELLS; HUMANS; HYDROXAMIC ACIDS; K562 CELLS; MUTATION; NUCLEIC ACID CONFORMATION; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; SEQUENCE ANALYSIS, DNA; TRANSGENES;

EID: 79958095398     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-232     Document Type: Article

References (35)

1. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Cell 2007, 128:683-92. 10.1016/j.cell.2007.01.029, 17320506.
2. Robertson KD. DNA methylation and human disease. Nat Rev Genet 2005, 6:597-610.
3. Weber M, Hellmann I, Stadler MB, Ramos L, Pääbo S, Rabhan M, Schübeler D. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 2007, 39:457-66. 10.1038/ng1990, 17334365.
4. Mohn F, Schübeler D. Genetics and epigenetics: stability and plasticity during cellular differentiation. Trends Genet 2009, 25:129-36. 10.1016/j.tig.2008.12.005, 19185382.
5. Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, Herb B, Ladd-Acosta C, Rho J, Loewer S, Miller J, Schlaeger T, Daley GQ, Feinberg AP. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009, 41:1350-3. 10.1038/ng.471, 2958040, 19881528.
6. Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, Yamochi T, Urano T, Furukawa K, Kwabi-Addo B, Gold DL, Sekido Y, Huang TH, Issa JP. Gene silencing in cancer by histone H3 trimethylation independent of promoter DNA methylation. Nat Genet 2008, 40:741-50. 10.1038/ng.159, 18488029.
7. Coolen MW, Stirzaker C, Song JZ, Stathan AL, Kassir Z, Moreno CS, Young AN, Varma V, Speed TP, Cowley M, Lacaze P, Kaplan W, Robinson MD, Clark SJ. Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity. Nat Cell Biol 2010, 12:235-46. 3058354, 20173741.
8. De La Rosa-Velázquez IA, Rincón-Arano H, Benítez-Bribiesca L, Recillas-Targa F. Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF. Cancer Res 2007, 67:2577-85. 10.1158/0008-5472.CAN-06-2024, 17363576.
9. Soto-Reyes E, Recillas-Targa F. Epigenetic regulation of the human p53 gene promoter by the CTCF transcription factor in transformed cell lines. Oncogene 2010, 29:2217-27. 10.1038/onc.2009.509, 20101205.
10. Butcher DT, Mancini-DiNardo DN, Archer TK, Rodenhiser DI. DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter. Int J Cancer 2004, 111:669-78. 10.1002/ijc.20324, 15252835.
11. Recillas-Targa F, De La Rosa-Velázquez IA, Soto-Reyes E, Benítez-Bribiesca L. Epigenetic boundaries of tumour suppressor gene promoters: the CTCF connection and its role in carcinogenesis. J Cell Mol Med 2006, 10:554-68. 10.1111/j.1582-4934.2006.tb00420.x, 16989720.
12. Witcher M, Emerson BM. Epigenetic silencing of the p16INK4a tumor suppressor is associated with loss of CTCF binding and a chromatin boundary. Mol Cell 2009, 34:271-84. 10.1016/j.molcel.2009.04.001, 2723750, 19450526.
13. Ohtani-Fujita N, Dryia TP, Rapaport JM, Fujita T, Matsumura S, Ozasa K, Watanabe Y, Hayashi K, Maeda K, Kinoshita S, Matsumura T, Ohnishi Y, Hotta Y, Takahashi R, Kato MV, Ishizaki K, Sasaki MS, Horsthemke B, Minoda K, Sakai T. Hypermethylation in retinoblastoma gene is associated with unilateral, sporadic retinoblastoma. Cancer Genet Cytogenet 1997, 98:43-9. 10.1016/S0165-4608(96)00395-0, 9309117.
14. Simpson DJ, Hibberts NA, McNicol AM, Clayton RN, Farrell WE. Loss of pRb expression in pituitary adenomas is associated with methylation of the Rb1 CpG island. Cancer Res 2000, 60:1211-6.
15. Nakamura M, Yonekawa Y, Kleihues P, Ohgaki H. Promoter hypermethylation of the RB1 gene in glioblastomas. Lab Invest 2001, 81:77-82.
16. Joseph B, Mamatha G, Raman G, Shanmugan MP, Kumaramanickavel G. Methylation status of RB1 promoter in indian retinoblastoma patients. Cancer Biol Ther 2004, 3:184-7.
17. Garrick D, Fiering S, Martin DI, Whitelaw E. Repeat-induced gene silencing in mammals. Nat Genet 1998, 18:56-9. 10.1038/ng0198-56, 9425901.
18. Recillas-Targa F, Valadez-Graham V, Farrell CM. Prospects and implications of using chromatin insulators in gene therapy and transgenesis. BioEssays 2004, 26:796-807. 10.1002/bies.20059, 15221861.
19. Calero-Nieto FJ, Bert AG, Cockerill PN. Transcription-dependent silencing of inducible convergent transgenes in transgenic mice. Epigenet Chromat 2010, 19:3.
20. Bell AC, Felsenfeld G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 2000, 405:482-5. 10.1038/35013100, 10839546.
21. Szabó P, Tang SH, Rentsendorj A, Pfeifer GP, Mann JR. Maternal-specific footprints at putative CTCF sites in the H19 imprinting control region give evidence for insulator function. Curr Biol 2000, 10:607-10. 10.1016/S0960-9822(00)00489-9, 10837224.
22. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004, 4:988-93. 10.1038/nrc1507, 15573120.
23. Phillips JE, Corces VG. CTCF: master weaver of the genome. Cell 2009, 137:1194-211. 10.1016/j.cell.2009.06.001, 3040116, 19563753.
24. Gomes NP, Espinosa JM. Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-cohesin binding. Genes Dev 2010, 24:1022-34. 10.1101/gad.1881010, 2867207, 20478995.
25. Jothi R, Cuddapah S, Barski A, Cui K, Zhao K. Genome-wide identification on in vivo protein-DNA binding sites from ChIP-Seq data. Nucleic Acids Res 2008, 16:5221-31.
26. Bose T, Gerton JL. Cohesinopathies, gene expression and chromatin organization. J Cell Biol 2010, 189:201-10. 10.1083/jcb.200912129, 2856913, 20404106.
27. McGarvey KM, Fahrner JA, Greene E, Martens J, Jenuwein T, Baylin SB. Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatin chromatin state. Cancer Res 2006, 66:3541-9. 10.1158/0008-5472.CAN-05-2481, 16585178.
28. Tiwari VK, McGarvey KM, Licchesi JD, Ohm JEm Herman JG, Schübeler D, Baylin SB. PcG proteins, DNA methylation, and gene repression by chromatin looping. PLoS Biol 2008, 6:2911-27. 2592355, 19053175.
29. McGarvey KM, Greene E, Fahrner JA, Jenuwein T, Baylin SB. DNA methylation and complete transcriptional silencing of cancer genes persist after depletion of EZH2. Cancer Res 2007, 67:5097-102. 10.1158/0008-5472.CAN-06-2029, 17545586.
30. Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, Yamochi T, Urano T, Furukawa K, Kwabi-Addo B, Gold DL, Sekido Y, Huang TH, Issa JP. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 2008, 40:741-50. 10.1038/ng.159, 18488029.
31. Jiang Z, Guo Z, Saad FA, Ellis J, Zacksenhaus E. Retinoblastoma gene promoter directs transgene expression exclusively to the nervous system. J Biol Chem 2001, 276:593-600.
32. Farrar D, Rai S, Chernukhin I, Jagodic M, Ito Y, Yammine S, Ohlsson R, Murrell A, Klenova E. Mutational analysis of the poly(ADP-ribosyl)ation sites of the transcription factor CTCF provides an insight into the mechanism of its regulation by poly(ADP-ribosyl)ation. Mol Cell Biol 2010, 30:1199-216. 10.1128/MCB.00827-09, 2820893, 20038529.
33. Guastafierro T, Cecchinelli B, Zampieri M, Reale A, Riggio G, Sthandier O, Zupi G, Calabrese L, Caiafa P. CCCTC-binding factor activates PARP-1 affecting DNA methylation machinery. J Biol Chem 2008, 283:21873-80. 10.1074/jbc.M801170200, 2494936, 18539602.
34. Gupsta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, Li R, West RB, van de Vijver MJ, Sukumars, Chan HY. Long non-coding RNA HOTAIR mediates global gene repression in the p53 response. Cell 2010, 142:409-19. 10.1016/j.cell.2010.06.040, 20673990.
35. Huarte A, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M, Attardi LD, Regev A, Lander ES, Jacks T, Rinn JL. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010, 142:409-19. 10.1016/j.cell.2010.06.040, 20673990.